Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
CCL17 is one of several Cys-Cys (CC) cytokine genes clustered on the q arm of chromosome 16. Additionally we are shipping CCL17 Kits (60) and CCL17 Proteins (51) and many more products for this protein.
Showing 10 out of 153 products:
Human Polyclonal CCL17 Primary Antibody for FACS - ABIN2660891
Oo, Weston, Lalor, Curbishley, Withers, Reynolds, Shetty, Harki, Shaw, Eksteen, Hubscher, Walker, Adams: Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver. in Journal of immunology (Baltimore, Md. : 1950) 2010
Show all 5 references for ABIN2660891
Human Polyclonal CCL17 Primary Antibody for WB - ABIN1881150
Dallos, Heiland, Strehl, Karonitsch, Gross, Moosig, Holl-Ulrich, Distler, Manger, Schett, Zwerina: CCL17/thymus and activation-related chemokine in Churg-Strauss syndrome. in Arthritis and rheumatism 2010
Show all 4 references for ABIN1881150
Human Polyclonal CCL17 Primary Antibody for IF (p), IHC (p) - ABIN2172678
Chen, Chiang: Targeting TSLP With shRNA Alleviates Airway Inflammation and Decreases Epithelial CCL17 in a Murine Model of Asthma. in Molecular therapy. Nucleic acids 2016
Show all 2 references for ABIN2172678
Human Monoclonal CCL17 Primary Antibody for FACS - ABIN4896819
Mizukami, Kono, Kawaguchi, Akaike, Kamimura, Sugai, Fujii: CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer. in International journal of cancer 2008
Show all 2 references for ABIN4896819
Human Polyclonal CCL17 Primary Antibody for ELISA, WB - ABIN4277207
van Roermund, Visser, Ijlst, Waterham, Wanders: Differential substrate specificities of human ABCD1 and ABCD2 in peroxisomal fatty acid β-oxidation. in Biochimica et biophysica acta 2011
Human Polyclonal CCL17 Primary Antibody for FACS, IHC (p) - ABIN656554
Maier, Mayerhofer, Asheuer, Köhler, Rothe, Muntau, Roscher, Holzinger, Aubourg, Berger: X-linked adrenoleukodystrophy phenotype is independent of ABCD2 genotype. in Biochemical and biophysical research communications 2008
Human Polyclonal CCL17 Primary Antibody for WB - ABIN653579
Saito, Kawamoto, Kamatani: Association study between single-nucleotide polymorphisms in 199 drug-related genes and commonly measured quantitative traits of 752 healthy Japanese subjects. in Journal of human genetics 2009
levels elevated in rheumatoid arthritis synovial fluid, due to production by mononuclear cells, particularly CD1c (show CD1C Antibodies) classical dendritic cells
Serum TARC levels are well correlated with blood eosinophil counts in patients with generalized drug eruptions, indicating that Th2-type immune reactions underlie TARC production. Serum TARC measurements also have potent diagnostic value for DIHS, with high sensitivity and specificity.
Data suggest that Th1 (show TH1L Antibodies) (IFN-gamma (show IFNG Antibodies)-inducible protein-10 IP-10/CXCL10 (show CXCL10 Antibodies)) and Th2 (thymus and activation regulated chemokine TARC/CCL17) and (macrophage derived chemokine MDC/CCL22 (show CCL22 Antibodies)) cooperatively play a role in the development of ankylosing spondylitis (AS).
CCL17 positively regulates the tumorigenesis of hepatocellular carcinoma.Higher levels of intratumoral CCL17 expression are associated with poorer survival of hepatocellular carcinoma patients.
CCL17 and CCL18 (show CCL18 Antibodies) dermal expression is associated with leprosy polarity.
The SNP rs223895 in TARC/CCL17 gene is associated with the susceptibility to Kawasaki disease.
Serum CCL17 levels are associated with coronary artery disease and atherosclerosis severity independently of traditional cardiovascular risk factors.
TARC was correlated with disease status and its monitoring may be able to predict PET positivity after alloSCT, thus potentially allowing an early immune manipulation.
Serum levels of CCL17 were positively correlated with coronary artery disease.
TARC and interleukin-31 (show IL31 Antibodies) may be biomarkers for adult atopic dermatitis
Aged mice had similar levels of IL-1beta (show IL1B Antibodies), TNF (show TNF Antibodies), IFN-gamma (show IFNG Antibodies), IL-17 (show IL17A Antibodies), and granulocyte colony-stimulating factor (show CSF3 Antibodies) following S. pneumoniae infection, compared with young mice, but increased levels of the chemokines CXCL9 (show CXCL9 Antibodies), CXCL12 (show CXCL12 Antibodies), CCL3 (show CCL3 Antibodies), CCL4 (show CCL4 Antibodies), CCL5 (show CCL5 Antibodies), CCL11 (show CCL11 Antibodies), and CCL17.
that effective engagement of CCR4 (show CCR4 Antibodies) by CCL17 involves two distinct binding domains and interaction with both is required for signaling
murine tumor-associated neutrophils secrete significant amounts of CCL17. Migration assays showed recruitment of T-regs by tumor-associated neutrophils, which was inhibited with anti-CCL17 monoclonal antibodies.
TSLP (show TSLP Antibodies) activated a subset of CD11b (show ITGAM Antibodies)(+) DCs in the skin to produce CCL17, upregulate CCR7 (show CCR7 Antibodies), and migrate to the draining lymph node to initiate Th2 differentiation.
CCL17 is required for induction of intestinal inflammation in mice and has an autocrine effect on dendritic cells that promotes production of inflammatory cytokines and activation of Th1 (show HAND1 Antibodies) and Th17 cells and reduces expansion of Treg cells.
Kinetics of CCL17 mRNA expression in an allergic contact dermatitis model.
Thymus and activation-regulated chemokine (TARC)/CC chemokine (show CCL1 Antibodies) ligand (CCL) 17 accelerates wound healing by enhancing fibroblast migration.
Data identify DC-derived CCL17 as a central regulator of Treg homeostasis, implicate DCs and their effector functions in atherogenesis, and suggest that CCL17 might be a target for vascular therapy.
Data show that mice deficient for CCL17 had an up to 4-fold higher worm burden compared with controls by day 10 of infection with the murine filaria Litomosoides sigmodontis.
The inducible chemokine (show CCL1 Antibodies) CCL17 sensitizes dendritic cells (DCs) for CCR7 (show CCR7 Antibodies)- and CXCR4 (show CXCR4 Antibodies)-dependent migration to lymph node-associated homeostatic chemokines under inflammatory conditions and thus plays an important role in cutaneous DC migration.
This gene is one of several Cys-Cys (CC) cytokine genes clustered on the q arm of chromosome 16. Cytokines are a family of secreted proteins involved in immunoregulatory and inflammatory processes. The CC cytokines are proteins characterized by two adjacent cysteines. The cytokine encoded by this gene displays chemotactic activity for T lymphocytes, but not monocytes or granulocytes. The product of this gene binds to chemokine receptors CCR4 and CCR8. This chemokine plays important roles in T cell development in thymus as well as in trafficking and activation of mature T cells.
chemokine (C-C motif) ligand 17
, C-C motif chemokine 17
, CC chemokine TARC
, T cell-directed CC chemokine
, small inducible cytokine subfamily A (Cys-Cys), member 17
, small-inducible cytokine A17
, thymus and activation-regulated chemokine
, small inducible cytokine subfamily A17
, chemokine ligand 17-like protein
, chemokine CCL17/TARC
, small inducible cytokine A17